Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science partner for this effort. The new lab aims to bolster Novartis AI capabilities from research through commercialization and help accelerate the discovery and development of transformative medicines for patients worldwide.
Patient Safety Learning today announced acampaign to end the thousands of avoidable deaths each year from unsafe patient care. The charity is calling for a new approach throughout all areas of the health and social care system to ensure improvements in patient safety. This involves providers, commissioners, policy makers, regulators, patient groups, and individual patients and families.
| Location: | Copenhagen, Denmark |
| Job Type: | Full-Time |
| Employer: | Novartis |
Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, announced that it has signed a new agreement with IBM Watson Health to co-develop and co-commercialize an artificial intelligence (AI) solution to help clinicians diagnose and monitor patients with prostate cancer.
Technological innovation has triggered an unprecedented increase in data production in health research and healthcare. The need to make EU health research data FAIR (i.e., Findable, Accessible, Interoperable and Re-usable) becomes more pressing than ever before if European health research is to reap the full benefits of this valuable resource.